How Hermès is bucking the global luxury slowdown
Paris-based luxury house Hermès has reported strong financial results despite a global slowdown that has affected competitors LVMH and Gucci owner Kering.
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.
Uber reports third-quarter results that beat Wall Street’s revenue expectations
Uber reported third-quarter results Thursday that beat analysts’ expectations for revenue.
Super Micro’s $50 billion stock collapse underscores risk of AI hype
Since being added to the S&P 500 in March, Super Micro has lost about two-thirds of its value and now faces the risk of Nasdaq delisting.
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.
Microsoft CFO says OpenAI investment will cut into profit this quarter
Microsoft has invested over $13 billion in OpenAI, a bet that’s weighing on the company’s profitability.
Starbucks will stop charging extra for dairy alternatives
The change to Starbucks’ policy could save some U.S. customers more than 10% on their drinks.
CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
The CDC believes the risk to the public is “very low” due to the actions taken by McDonald’s and Taylor Farms to remove slivered onions from affected locations.
EBay stock sinks after lackluster Q4 guidance, election distraction
EBay reported better-than-expected earnings for the third quarter, but the results were overshadowed by a disappointing forecast for the current period.
Carvana raises 2024 earnings guidance after topping Wall Street’s Q3 expectations
Carvana said its adjusted EBITDA would be “significantly above the high end” of its previous target of $1 billion to $1.2 billion.
